Embed

Academic

Authors

Joyce A. O’Shaughnessy

Joyce A. O’Shaughnessy,University of Texas Southwestern Medical Center,Oncology,Anatomy,Genetics & Genealogy

Edit

Joyce A. O’Shaughnessy

University of Texas Southwestern Medical Center

Publications: 119 | Citations: 1662

Fields: Oncology, Anatomy, Genetics & Genealogy

Collaborated with 417 co-authors from 1992 to 2011 | Cited by 5398 authors

Cumulative Annual

Sort by:

Publications (119)

BibTeX | RIS | RefWorks Download

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study (Citations: 5)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=49174512&selfId1=23575678&selfId2=0&maxNumber=12&query=

Journal: Lancet , vol. 377, no. 9769, pp. 914-923, 2011

Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer

, , , , , , , , ,

Journal: Breast Cancer Research and Treatment - BREAST CANCER RES TREAT , vol. 126, no. 1, pp. 101-108, 2011

5006 ORAL Eribulin Mesylate EMBRACE Study – Survival Analysis Excluding Patients Re-challenged With Therapies of the Same Class

, , , , , , ,

Journal: European Journal of Cancer - EUR J CANCER , vol. 47, pp. S331-S332, 2011

Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab -paclitaxel is safe in women with early-stage breast cancer: a pilot study

, , , , ,

Journal: Breast Cancer Research and Treatment - BREAST CANCER RES TREAT , vol. 125, no. 1, pp. 115-120, 2011

P272 Randomized, phase III study of adjuvant doxorubicin plus cyclophosphamide (AC), followed by docetaxel (T) with or without capecitabine (X), in high-risk early breast cancer (EBC): efficacy results

, , ,

Journal: Breast , vol. 20, pp. S65-S65, 2011

Sort by:

Citations (1662 times by 1360 publications)

Regulation of mitosis and taxane response by Daxx and Rassf1

, , , , , , ,

Journal: Oncogene , vol. 31, no. 1, pp. 13-26, 2012

Breast cancerHER2—a good addiction

Journal: Nature Reviews Clinical Oncology - NAT REV CLIN ONCOL , vol. 9, no. 4, pp. 196-197, 2012

Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy (Citations: 3)

, , , , ,

Journal: Supportive Care in Cancer - SUPPORT CARE CANCER , vol. 19, no. 4, pp. 497-504, 2011

miRNA expression profiling of mycosis fungoides (Citations: 3)

, , , , , , , , , ,

Journal: Molecular Oncology - MOL ONCOL , vol. 5, no. 3, pp. 273-280, 2011

Tumor delivery of macromolecular drugs based on the EPR effect (Citations: 8)

Journal: Advanced Drug Delivery Reviews - ADVAN DRUG DELIVERY REV , vol. 63, no. 3, pp. 131-135, 2011

Comments

Co-authors (417)

Journals (33)

Keywords (181)

Joyce A. O’Shaughnessy,University of Texas Southwestern Medical Center,Oncology,Anatomy,Genetics & Genealogy

Publications (119)

BibTeX | RIS | RefWorks Download

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study (Citations: 5)

Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer

5006 ORAL Eribulin Mesylate EMBRACE Study – Survival Analysis Excluding Patients Re-challenged With Therapies of the Same Class

Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab -paclitaxel is safe in women with early-stage breast cancer: a pilot study

P272 Randomized, phase III study of adjuvant doxorubicin plus cyclophosphamide (AC), followed by docetaxel (T) with or without capecitabine (X), in high-risk early breast cancer (EBC): efficacy results

Citations (1662 times by 1360 publications)

Regulation of mitosis and taxane response by Daxx and Rassf1

Breast cancerHER2—a good addiction

Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy (Citations: 3)

miRNA expression profiling of mycosis fungoides (Citations: 3)

Tumor delivery of macromolecular drugs based on the EPR effect (Citations: 8)


	View FAQ about top research areas and Fields of study

Joyce A. O’Shaughnessy,University of Texas Southwestern Medical Center,Oncology,Anatomy,Genetics & Genealogy

Publications (119) BibTeX | RIS | RefWorks Download

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study (Citations: 5)

Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy (Citations: 3)

miRNA expression profiling of mycosis fungoides (Citations: 3)

Tumor delivery of macromolecular drugs based on the EPR effect (Citations: 8)

Publications (119)

BibTeX | RIS | RefWorks Download